Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Polymyositis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00106184
What this trial is testing

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

Who this might be right for
MyositisDermatomyositisPolymyositis+1 more
University of Pittsburgh 200
Not applicableLooking for participantsNCT00017914
What this trial is testing

Adult and Juvenile Myositis

Who this might be right for
DermatomyositisPolymyositisInclusion Body Myositis
National Institute of Environmental Health Sciences (NIEHS) 1,200
Not applicableStudy completedNCT01734369
What this trial is testing

Environmental Risk Factors for Myositis in Military Personnel

Who this might be right for
DermatomyositisAdult PolymyositisInclusion Body Myositis+1 more
National Institute of Environmental Health Sciences (NIEHS) 37
Testing effectiveness (Phase 2)Study completedNCT06433999
What this trial is testing

A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis

Who this might be right for
DermatomyositisDermatomyositis, Adult Type
Priovant Therapeutics, Inc. 5
Early research (Phase 1)Looking for participantsNCT06916806
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesRheumatoid Arthritis
AstraZeneca 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT06284954
What this trial is testing

Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

Who this might be right for
DermatomyositisMyositis
argenx 3
Testing effectiveness (Phase 2)Looking for participantsNCT07089121
What this trial is testing

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

Who this might be right for
Childhood-onset Systemic Lupus ErythematousANCA-Associated Vasculitis (AAV)Juvenile Myasthenia Gravis+1 more
Cartesian Therapeutics 50
Post-approval studies (Phase 4)UnknownNCT05375435
What this trial is testing

Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis

Who this might be right for
Dermatomyositis, Adult TypeInterstitial Lung Disease
The First Affiliated Hospital with Nanjing Medical University 120
Large-scale testing (Phase 3)Looking for participantsNCT06455449
What this trial is testing

Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Who this might be right for
Polymyositis, Dermatomyositis
AstraZeneca 240
Not applicableLooking for participantsNCT01276470
What this trial is testing

Environmental Risk Factors for the Anti-synthetase Syndrome

Who this might be right for
MyositisDermatomyositisPolymyositis+2 more
National Institute of Environmental Health Sciences (NIEHS) 580
Testing effectiveness (Phase 2)WithdrawnNCT07012057
What this trial is testing

Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis

Who this might be right for
MyositisDermatomyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Early research (Phase 1)UnknownNCT05986162
What this trial is testing

Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis

Who this might be right for
Dermatomyositis, Adult Type
Biotech Pharmaceutical Co., Ltd. 44
Post-approval studies (Phase 4)UnknownNCT04966884
What this trial is testing

The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients

Who this might be right for
Dermatomyositis, Adult Type
First Affiliated Hospital Xi'an Jiaotong University 20
Testing effectiveness (Phase 2)Study completedNCT03529955
What this trial is testing

Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis

Who this might be right for
Dermatomyositis, Adult Type
Tulane University 8
Large-scale testing (Phase 3)Study completedNCT03267277
What this trial is testing

Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis

Who this might be right for
DermatomyositisIdiopathic Inflammatory Myopathies
National Institute of Environmental Health Sciences (NIEHS) 15
Testing effectiveness (Phase 2)Study completedNCT05669014
What this trial is testing

Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)

Who this might be right for
Idiopathic Inflammatory Myositis
Amgen 12
Testing effectiveness (Phase 2)Study completedNCT02612857
What this trial is testing

Trial of IMO-8400 in Adult Patients With Dermatomyositis

Who this might be right for
Dermatomyositis
Idera Pharmaceuticals, Inc. 30